Catheter Ablation For Supraventricular Tachycardia Wolff Parkinson White Syndrome
Category : Health » Parkinson Disease
Wolff-Parkinson-White Syndrome is the second most common cause of regular . The syndrome was named after doctors Wolff, Parkinson and White .
Download File
Free PDF eBooks Download
Health
Parkinson Disease
Content Summary :
Wolff-Parkinson-White Syndrome (WPW Syndrome) Introduction Wolff-Parkinson-White Syndrome is the second most common cause of regular supraventricular tachycardia in adults, and by far the most common cause of supraventricular tachycardia in the babies and children. The syndrome is caused by a residual congenital muscle fiber that crosses the normally-insulated valve rings that separate the upper and lower chambers of your heart (the atria and ventricles) called an "accessory pathway." The syndrome was named after doctors Wolff, Parkinson and White who noticed an abnormal electrocardiogram ("ECG" or "EKG" ) finding in 19 athletic males who all had racing heart rhythms. This abnormal EKG finding (called a "delta wave") allows doctors today to diagnose some individuals by their EKG alone. Patients who have a "delta wave" on their EKG but no symptoms to NOT necesarily require treatment of this finding, but those that have symptoms of palpitations or a racing heart rhythm are often recommended to undergo a heart electrical study called an "electrophysiology study" (or "EPS" or "EP Study" for short).
Favorite Parkinson Disease PDF File
Department of Neurology Department of Neurology. Parkinson Center of Oregon . No part of this book may be reproduced or transmitted in any form or by any .
Adult Stem Cells Treat Parkinson 39 s in Humans and Animals . This treatment provided. an average 61 improvement in motor function. .
primary treatment for symptomatic Parkinson 39 s disease . are effective treatments for these patients. 30. Nonpharmacologic Treatment .
set Parkinson 39 s starting before age 21 years fre . Parkinson 39 s Disease. Treatment Complications. Exercise and Nutrition. The Workplace .
new treatment opportunities. and therapies available to. people with Parkinson 39 s disease. . in Parkinson 39 s. Treatment. SPRING CONFERENCE Approved for 2 .